Analystreport

Odonate Therapeutics Inc (NASDAQ: ODT) had its "buy" rating re-affirmed by analysts at Ci Capital. They now have a $50.00 price target on the stock.

Odonate Therapeutics, Inc.  (ODT) 
Last odonate therapeutics, inc. earnings: 4/28 08:15 am Check Earnings Report
US:NASDAQ Investor Relations: ir.odonate.com/contact-ir